Large language models (LLMs) are explored as clinical decision-support tools in complex medical fields. However, their reliability and clinical usefulness in multidisciplinary management of pituitary adenomas remain insufficiently evaluated using validated, clinician-based frameworks. Do LLMs differ in informational quality, clinical reasoning, and expert satisfaction when applied to pituitary adenoma–related clinical scenarios? A prospective comparative study evaluated three LLMs: ChatGPT-5.0, Claude Opus 4.1, and Gemini 2.5 Flash. A standardized prompt set covering general knowledge, surgical decision-making, endocrine evaluation, patient education, and MRI-based scenarios was submitted to each model identically. Outputs were anonymized and independently assessed by 10 board-certified doctors using three validated instruments: the Quality Assessment of Medical Artificial Intelligence (QAMAI), the Artificial Intelligence Performance Instrument (AIPI), and the Artificial Intelligence Satisfaction and Performance Evaluation Questionnaire (AISPE-Q). Claude Opus 4.1 achieved the highest performance across all major domains. Aggregate QAMAI scores were highest for Claude Opus 4.1 (4.39 ± 0.66), compared with ChatGPT-5.0 (4.12 ± 0.74) and Gemini 2.5 Flash (4.07 ± 0.76; p = 0.018). Clinical reasoning assessed by AIPI was superior for Claude Opus 4.1 versus Gemini 2.5 Flash and ChatGPT-5.0. Strong correlations were observed between informational quality, reasoning performance, and satisfaction. LLMs exhibit significant variability in performance when managing pituitary adenomas. Claude Opus 4.1 demonstrated the highest levels of informational quality, reasoning depth, and expert trust. While LLMs may serve as supportive adjuncts in multidisciplinary pituitary care, structured evaluation and expert oversight remain essential before clinical integration. 2 – Prospective comparative diagnostic accuracy study.
Background: Intracranial meningiomas are vascular tumors often causing significant intraoperative blood loss. Preoperative embolization (POE) aims to reduce vascularity and improve outcomes, though its efficacy is debated. This systematic review and meta-analysis evaluate the impact of POE on operative and postoperative outcomes in intracranial meningioma surgery. Methods: Following Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines, a literature search from 2017 to 2025 identified 13 English-language, non-randomized studies comparing POE to no embolization. Outcomes included intraoperative blood loss, operative time, extent of resection, complications, and tumor recurrence. Due to heterogeneity, a meta-analysis was performed where possible, supplemented by a narrative synthesis. Risk of bias assessment was performed. Results: Meta-analysis revealed that POE significantly reduced complications (odds ratio [OR] 0.68, 95% confidence interval [CI] 0.53–0.88) and increased the likelihood of achieving gross total resection (GTR) (pooled OR 0.61, 95% CI 0.46–0.80). In contrast, findings on intraoperative blood loss and operative time were highly inconsistent with extreme heterogeneity. Tumor recurrence data were extremely limited, reported in only on study, precluding synthesis on long-term outcomes. Significant methodological variability was identified. Conclusion: POE consistently improves the likelihood of achieving GTR in intracranial meningiomas. However, its benefits in reducing intraoperative blood loss and operative time remain inconsistent. Neurosurgeons should consider POE when maximal resection is the primary surgical goal, especially for highly vascular tumors. Future research requires robust designs, such as matched-cohort studies or randomized controlled trials, to definitively establish its precise role.
Background: Trigeminal neuralgia (TN) is a severe neuropathic pain disorder for which a significant proportion of patients require surgical intervention following failure of pharmacological therapy. Despite the availability of multiple surgical and neuromodulatory options, there is no unified, evidence-informed framework to guide procedure selection across different clinical scenarios. Objective: To synthesize contemporary evidence on surgical and neuromodulatory interventions for TN and to develop a structured clinical decision algorithm to support patient-specific management. Methods: A focused evidence synthesis was conducted using PubMed/MEDLINE, Embase, Web of Science, and Cochrane databases for studies published between January 2016 and January 2026. Eligibility was restricted to high-level evidence, including systematic reviews, meta-analyses, large clinical series, and consensus guidelines. Data on study design, patient population, intervention type, outcomes, and complications were extracted and synthesized narratively. Based on the synthesized evidence, a stepwise clinical decision algorithm was developed. Results: Six high-quality sources met the inclusion criteria. Microvascular decompression (MVD) demonstrated the highest rates of initial pain freedom (85–96%) and the lowest long-term recurrence, particularly in patients with MRI-confirmed arterial neurovascular conflict. Stereotactic radiosurgery (SRS) offered a favorable safety profile with moderate durability but higher recurrence rates. Percutaneous procedures provided effective minimally invasive alternatives, with selection guided by patient-specific factors. Peripheral nerve stimulation was identified as a viable option in refractory cases. Key limitations in the evidence base include the absence of randomized comparative trials and heterogeneity in outcome reporting. Conclusions: Current evidence supports a stratified, patient-centered approach to the surgical management of TN. The proposed clinical algorithm integrates available data into a structured framework to support decision-making in clinical practice. Further prospective validation and standardized outcome reporting are required to strengthen the evidence base.